Retrospective analysis of the clinical characteristics and patient-reported outcomes in vulval lichen planus: Results from a single-center study

Keyphrases

• Retrospective Analysis 100%
• Clinical Characteristics 100%
• Clinical Patients 100%
• Patient-reported Outcomes 100%
• Single-center Study 100%
• Vulvar Lichen Planus 100%
• Scar 27%
• Quality of Life 18%
• Erythema 18%
• Mean Standard Deviation 18%
• Adhesion 9%
• Clinical Features 9%
• Chronic Inflammatory Diseases 9%
• Symptomatology 9%
• Clinical Manifestations 9%
• Dyspareunia 9%
• Current Treatment 9%
• Follow-up Time 9%
• Index Score 9%
• Hydroxychloroquine 9%
• Anatomical Location 9%
• Patient Demographics 9%
• Corticosteroids 9%
• Life Impairments 9%
• Vulvar Squamous Cell Carcinoma 9%
• Clitoris 9%
• Labia Minora 9%
• Topical Corticosteroids 9%
• Systemic Therapy 9%
• Acitretin 9%
• Dermatology Life Quality Index 9%
• Cutaneous Involvement 9%
• Life Management 9%
• Genital Pain 9%
• Oral mucosal Involvement 9%
• Clinical Outcomes 9%
• Clinical Comorbidities 9%

Medicine and Dentistry

• Patient-Reported Outcome 100%
• Lichen Planus 100%
• Scar Formation 27%
• Erythema 18%
• Quality of Life 18%
• Symptom 9%
• Clinical Feature 9%
• Symptomatology 9%
• Squamous Cell Carcinoma 9%
• Clinical Finding 9%
• Dyspareunia 9%
• Inflammatory Disorder 9%
• Hydroxychloroquine 9%
• Study Participant 9%
• Labia Minora 9%
• Clitoris 9%
• Topical Corticosteroid 9%
• Systemic Therapy 9%
• Clinical Management 9%
• Dermatology Life Quality Index 9%
• Genital Pain 9%
• Etretin 9%